Concepedia

Publication | Open Access

A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies

DOIFull Paper Access

65

Citations

21

References

2011

Year

Hendrik‐Tobias Arkenau, Ruth Plummer, L. Rhoda Molife, David Olmos, Timothy A. Yap, Matthew Squires, Sara Lewis, Victoria Lock, Murray Yule, John F. Lyons,
Annals of Oncology

References

YearCitations

Page 1